LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article ; Online: RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer

    Olav Engebraaten / Christina Yau / Kristian Berg / Elin Borgen / Øystein Garred / Maria E. B. Berstad / Ane S. V. Fremstedal / Angela DeMichele / Laura van ’t Veer / Laura Esserman / Anette Weyergang

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Volume 11

    Abstract: Antibody Drug Conjugates (ADCs) are emerging in the field of precision cancer medicine. Here, the authors suggest using endocytosis as a predictive biomarker for ... ...

    Abstract Antibody Drug Conjugates (ADCs) are emerging in the field of precision cancer medicine. Here, the authors suggest using endocytosis as a predictive biomarker for response
    Keywords Science ; Q
    Language English
    Publishing date 2021-11-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer

    A. Gordon Robertson / Christina Yau / Jian Carrot-Zhang / Jeffrey S. Damrauer / Theo A. Knijnenburg / Nyasha Chambwe / Katherine A. Hoadley / Anab Kemal / Jean C. Zenklusen / Andrew D. Cherniack / Rameen Beroukhim / Wanding Zhou

    STAR Protocols, Vol 2, Iss 2, Pp 100483- (2021)

    2021  

    Abstract: Summary: Cellular and molecular aberrations contribute to the disparity of human cancer incidence and etiology between ancestry groups. Multiomics profiling in The Cancer Genome Atlas (TCGA) allows for querying of the molecular underpinnings of ancestry- ... ...

    Abstract Summary: Cellular and molecular aberrations contribute to the disparity of human cancer incidence and etiology between ancestry groups. Multiomics profiling in The Cancer Genome Atlas (TCGA) allows for querying of the molecular underpinnings of ancestry-specific discrepancies in human cancer. Here, we provide a protocol for integrative associative analysis of ancestry with molecular correlates, including somatic mutations, DNA methylation, mRNA transcription, miRNA transcription, and pathway activity, using TCGA data. This protocol can be generalized to analyze other cancer cohorts and human diseases.For complete details on the use and execution of this protocol, please refer to Carrot-Zhang et al. (2020).
    Keywords Bioinformatics ; Cancer ; Genomics ; Science (General) ; Q1-390
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

    Joyce V. Lee / Filomena Housley / Christina Yau / Rachel Nakagawa / Juliane Winkler / Johanna M. Anttila / Pauliina M. Munne / Mariel Savelius / Kathleen E. Houlahan / Daniel Van de Mark / Golzar Hemmati / Grace A. Hernandez / Yibing Zhang / Susan Samson / Carole Baas / Laura J. Esserman / Laura J. van ‘t Veer / Hope S. Rugo / Christina Curtis /
    Juha Klefström / Mehrdad Matloubian / Andrei Goga

    Nature Communications, Vol 13, Iss 1, Pp 1-

    2022  Volume 12

    Abstract: The oncoprotein c-Myc is often overexpressed in triple negative breast cancer and has a role in tumor progression and resistance to therapy. Here the authors show that elevated MYC expression is correlated with low immune infiltration, diminished MHC-I ... ...

    Abstract The oncoprotein c-Myc is often overexpressed in triple negative breast cancer and has a role in tumor progression and resistance to therapy. Here the authors show that elevated MYC expression is correlated with low immune infiltration, diminished MHC-I pathway expression and that CpG/aOX40 treatment could overcome resistance to PD-L1 blockade in MYC-high breast tumors.
    Keywords Science ; Q
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Author Correction

    Joyce V. Lee / Filomena Housley / Christina Yau / Rachel Nakagawa / Juliane Winkler / Johanna M. Anttila / Pauliina M. Munne / Mariel Savelius / Kathleen E. Houlahan / Daniel Van de Mark / Golzar Hemmati / Grace A. Hernandez / Yibing Zhang / Susan Samson / Carole Baas / Marleen Kok / Laura J. Esserman / Laura J. van ‘t Veer / Hope S. Rugo /
    Christina Curtis / Juha Klefström / Mehrdad Matloubian / Andrei Goga

    Nature Communications, Vol 13, Iss 1, Pp 1-

    Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

    2022  Volume 2

    Keywords Science ; Q
    Language English
    Publishing date 2022-11-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity.

    Denise M Wolf / Marc E Lenburg / Christina Yau / Aaron Boudreau / Laura J van 't Veer

    PLoS ONE, Vol 9, Iss 2, p e

    2014  Volume 88309

    Abstract: Co-expression modules are groups of genes with highly correlated expression patterns. In cancer, differences in module activity potentially represent the heterogeneity of phenotypes important in carcinogenesis, progression, or treatment response. To find ...

    Abstract Co-expression modules are groups of genes with highly correlated expression patterns. In cancer, differences in module activity potentially represent the heterogeneity of phenotypes important in carcinogenesis, progression, or treatment response. To find gene expression modules active in breast cancer subpopulations, we assembled 72 breast cancer-related gene expression datasets containing ∼5,700 samples altogether. Per dataset, we identified genes with bimodal expression and used mixture-model clustering to ultimately define 11 modules of genes that are consistently co-regulated across multiple datasets. Functionally, these modules reflected estrogen signaling, development/differentiation, immune signaling, histone modification, ERBB2 signaling, the extracellular matrix (ECM) and stroma, and cell proliferation. The Tcell/Bcell immune modules appeared tumor-extrinsic, with coherent expression in tumors but not cell lines; whereas most other modules, interferon and ECM included, appeared intrinsic. Only four of the eleven modules were represented in the PAM50 intrinsic subtype classifier and other well-established prognostic signatures; although the immune modules were highly correlated to previously published immune signatures. As expected, the proliferation module was highly associated with decreased recurrence-free survival (RFS). Interestingly, the immune modules appeared associated with RFS even after adjustment for receptor subtype and proliferation; and in a multivariate analysis, the combination of Tcell/Bcell immune module down-regulation and proliferation module upregulation strongly associated with decreased RFS. Immune modules are unusual in that their upregulation is associated with a good prognosis without chemotherapy and a good response to chemotherapy, suggesting the paradox of high immune patients who respond to chemotherapy but would do well without it. Other findings concern the ECM/stromal modules, which despite common themes were associated with different sites of metastasis, possibly ...
    Keywords Medicine ; R ; Science ; Q
    Subject code 570
    Language English
    Publishing date 2014-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Analysis of germline-driven ancestry-associated gene expression in cancers

    Nyasha Chambwe / Rosalyn W. Sayaman / Donglei Hu / Scott Huntsman / Anab Kemal / Samantha Caesar-Johnson / Jean C. Zenklusen / Elad Ziv / Rameen Beroukhim / Andrew D. Cherniack / Jian Carrot-Zhang / Ashton C. Berger / Seunghun Han / Matthew Meyerson / Jeffrey S. Damrauer / Katherine A. Hoadley / Ina Felau / John A. Demchok / Michael K.A. Mensah /
    Roy Tarnuzzer / Zhining Wang / Liming Yang / Theo A. Knijnenburg / A. Gordon Robertson / Christina Yau / Christopher Benz / Kuan-lin Huang / Justin Y. Newberg / Garrett M. Frampton / R. Jay Mashl / Li Ding / Alessandro Romanel / Francesca Demichelis / Wanding Zhou / Peter W. Laird / Hui Shen / Christopher K. Wong / Joshua M. Stuart / Alexander J. Lazar / Xiuning Le / Ninad Oak

    STAR Protocols, Vol 3, Iss 3, Pp 101586- (2022)

    2022  

    Abstract: Summary: Differential mRNA expression between ancestry groups can be explained by both genetic and environmental factors. We outline a computational workflow to determine the extent to which germline genetic variation explains cancer-specific molecular ... ...

    Abstract Summary: Differential mRNA expression between ancestry groups can be explained by both genetic and environmental factors. We outline a computational workflow to determine the extent to which germline genetic variation explains cancer-specific molecular differences across ancestry groups. Using multi-omics datasets from The Cancer Genome Atlas (TCGA), we enumerate ancestry-informative markers colocalized with cancer-type-specific expression quantitative trait loci (e-QTLs) at ancestry-associated genes. This approach is generalizable to other settings with paired germline genotyping and mRNA expression data for a multi-ethnic cohort.For complete details on the use and execution of this protocol, please refer to Carrot-Zhang et al. (2020), Robertson et al. (2021), and Sayaman et al. (2021). : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.
    Keywords Bioinformatics ; Sequence analysis ; Cancer ; Genomics ; RNAseq ; Gene Expression ; Science (General) ; Q1-390
    Language English
    Publishing date 2022-09-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway

    Jian Carrot-Zhang / Xiaotong Yao / Siddhartha Devarakonda / Aditya Deshpande / Jeffrey S. Damrauer / Tiago Chedraoui Silva / Christopher K. Wong / Hyo Young Choi / Ina Felau / A. Gordon Robertson / Mauro A.A. Castro / Lisui Bao / Esther Rheinbay / Eric Minwei Liu / Tuan Trieu / David Haan / Christina Yau / Toshinori Hinoue / Yuexin Liu /
    Ofer Shapira / Kiran Kumar / Karen L. Mungall / Hailei Zhang / Jake June-Koo Lee / Ashton Berger / Galen F. Gao / Binyamin Zhitomirsky / Wen-Wei Liang / Meng Zhou / Sitapriya Moorthi / Alice H. Berger / Eric A. Collisson / Michael C. Zody / Li Ding / Andrew D. Cherniack / Gad Getz / Olivier Elemento / Christopher C. Benz / Josh Stuart / J.C. Zenklusen / Rameen Beroukhim / Jason C. Chang / Joshua D. Campbell / D. Neil Hayes / Lixing Yang / Peter W. Laird / John N. Weinstein / David J. Kwiatkowski / Ming S. Tsao / William D. Travis

    Cell Reports, Vol 34, Iss 8, Pp 108784- (2021)

    2021  

    Keywords Biology (General) ; QH301-705.5
    Language English
    Publishing date 2021-02-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Analytical protocol to identify local ancestry-associated molecular features in cancer

    Jian Carrot-Zhang / Seunghun Han / Wanding Zhou / Jeffrey S. Damrauer / Anab Kemal / Andrew D. Cherniack / Rameen Beroukhim / Ashton C. Berger / Matthew Meyerson / Katherine A. Hoadley / Ina Felau / Samantha Caesar-Johnson / John A. Demchok / Michael K.A. Mensah / Roy Tarnuzzer / Zhining Wang / Liming Yang / Jean C. Zenklusen / Nyasha Chambwe /
    Theo A. Knijnenburg / A. Gordon Robertson / Christina Yau / Christopher Benz / Kuan-lin Huang / Justin Newberg / Garret Frampton / R. Jay Mashl / Li Ding / Alessandro Romanel / Francesca Demichelis / Rosalyn W. Sayaman / Elad Ziv / Peter W. Laird / Hui Shen / Christopher K. Wong / Joshua M. Stuart / Alexander J. Lazar / Xiuning Le / Ninad Oak

    STAR Protocols, Vol 2, Iss 4, Pp 100766- (2021)

    2021  

    Abstract: Summary: People of different ancestries vary in cancer risk and outcome, and their molecular differences may indicate sources of these variations. Determining the “local” ancestry composition at each genetic locus across ancestry-admixed populations can ... ...

    Abstract Summary: People of different ancestries vary in cancer risk and outcome, and their molecular differences may indicate sources of these variations. Determining the “local” ancestry composition at each genetic locus across ancestry-admixed populations can suggest causal associations. We present a protocol to identify local ancestry and detect the associated molecular changes, using data from the Cancer Genome Atlas. This workflow can be applied to cancer cohorts with matched tumor and normal data from admixed patients to examine germline contributions to cancer.For complete details on the use and execution of this protocol, please refer to Carrot-Zhang et al. (2020).
    Keywords Bioinformatics ; Cancer ; Genomics ; Science (General) ; Q1-390
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.

    Michael J Campbell / Denise Wolf / Rita A Mukhtar / Vickram Tandon / Christina Yau / Alfred Au / Frederick Baehner / Laura van't Veer / Donald Berry / Laura J Esserman

    PLoS ONE, Vol 8, Iss 10, p e

    2013  Volume 79114

    Abstract: Tumor associated macrophages (TAMs) are recruited from the circulation to the tumor site, and can undergo a spectrum of phenotypic changes, with two contrasting activation states described in the literature: the M1 and M2 phenotypes. We previously ... ...

    Abstract Tumor associated macrophages (TAMs) are recruited from the circulation to the tumor site, and can undergo a spectrum of phenotypic changes, with two contrasting activation states described in the literature: the M1 and M2 phenotypes. We previously identified a population of TAMs that express proliferating cell nuclear antigen (PCNA) and are associated with high grade, hormone receptor negative breast cancers and poor outcomes. In the present exploratory study we again found that high PCNA(+) TAM counts in pre-treatment tumor biopsies (102 invasive breast cancer cases from the I-SPY 1 Trial, a prospective neoadjuvant trial with serial core biopsies and gene array data) were associated with high grade, hormone receptor negativity, and decreased recurrence free survival. We explored the association of these PCNA(+) TAMs with the expression of M1 and M2 related genes and, contrary to expectation, observed that high PCNA(+) TAM levels were associated with more M1- than M2-related genes. An immune gene signature, derived from cytotoxic T cell and MHC Class II genes (Tc/ClassII), was developed and we found that high PCNA(+) TAM counts, in the context of a low Tc/ClassII signature score, were associated with significantly worse recurrence free survival in all cases and in hormone receptor negative only cases. We observed similar results using a gene signature-proxy for PCNA(+) TAMs in a larger independent set of 425 neoadjuvant-treated breast cancer cases. The results of this exploratory study indicate that high numbers of PCNA(+) TAMs, in the absence of an anti-tumor immune microenvironment (as indicated by a low Tc/ClassII signature score), are associated with poor outcomes in breast cancer patients treated with neoadjuvant chemotherapy. This, along with the observation that PCNA(+) TAMs were associated predominantly with M1-related genes, may provide new insights into the role of the immune microenvironment in breast cancer.
    Keywords Medicine ; R ; Science ; Q
    Subject code 616
    Language English
    Publishing date 2013-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

    Amy S. Clark / Christina Yau / Denise M. Wolf / Emanuel F. Petricoin / Laura J. van ‘t Veer / Douglas Yee / Stacy L. Moulder / Anne M. Wallace / A. Jo Chien / Claudine Isaacs / Judy C. Boughey / Kathy S. Albain / Kathleen Kemmer / Barbara B. Haley / Hyo S. Han / Andres Forero-Torres / Anthony Elias / Julie E. Lang / Erin D. Ellis /
    Rachel Yung / Debu Tripathy / Rita Nanda / Julia D. Wulfkuhle / Lamorna Brown-Swigart / Rosa I. Gallagher / Teresa Helsten / Erin Roesch / Cheryl A. Ewing / Michael Alvarado / Erin P. Crane / Meredith Buxton / Julia L. Clennell / Melissa Paoloni / Smita M. Asare / Amy Wilson / Gillian L. Hirst / Ruby Singhrao / Katherine Steeg / Adam Asare / Jeffrey B. Matthews / Scott Berry / Ashish Sanil / Michelle Melisko / Jane Perlmutter / Hope S. Rugo / Richard B. Schwab / W. Fraser Symmans / Nola M. Hylton / Donald A. Berry / Laura J. Esserman

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Volume 11

    Abstract: HER2-targeted therapy improves patient’s outcome in early breast cancer. Here, the authors present the efficacy and biomarker analysis of two HER2-targeted combinations (ado-trastuzumab emtansine plus pertuzumab and paclitaxel, trastuzumab and pertuzumab) ...

    Abstract HER2-targeted therapy improves patient’s outcome in early breast cancer. Here, the authors present the efficacy and biomarker analysis of two HER2-targeted combinations (ado-trastuzumab emtansine plus pertuzumab and paclitaxel, trastuzumab and pertuzumab) in the context of the neoadjuvant I-SPY2 phase 2 adaptive platform trial for early breast cancer at high risk of recurrence.
    Keywords Science ; Q
    Language English
    Publishing date 2021-11-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top